Sen. Grassley's Proposed Drug Safety Office Would Have Labeling Authority
This article was originally published in The Pink Sheet Daily
Executive Summary
Finance Committee chairman is considering the feasibility of giving an independent drug safety office authority to suspend direct-to-consumer ads and marketing. The senator expects to offer legislation that would create the drug safety office soon, although the timeline may change based upon other legislators' actions.